» Articles » PMID: 36364149

7-Hydroxycoumarin Induces Vasorelaxation in Animals with Essential Hypertension: Focus on Potassium Channels and Intracellular Ca Mobilization

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2022 Nov 11
PMID 36364149
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiovascular diseases (CVD) are the deadliest noncommunicable disease worldwide. Hypertension is the most prevalent risk factor for the development of CVD. Although there is a wide range of antihypertensive drugs, there still remains a lack of blood pressure control options for hypertensive patients. Additionally, natural products remain crucial to the design of new drugs. The natural product 7-hydroxycoumarin (7-HC) exhibits pharmacological properties linked to antihypertensive mechanisms of action. This study aimed to evaluate the vascular effects of 7-HC in an experimental model of essential hypertension. The isometric tension measurements assessed the relaxant effect induced by 7-HC (0.001 μM-300 μM) in superior mesenteric arteries isolated from hypertensive rats (SHR, 200-300 g). Our results suggest that the relaxant effect induced by 7-HC rely on K-channels (K, BK, and, to a lesser extent, K) activation and also on Ca influx from sarcolemma and sarcoplasmic reticulum mobilization (inositol 1,4,5-triphosphate (IP3) and ryanodine receptors). Moreover, 7-HC diminishes the mesenteric artery's responsiveness to α1-adrenergic agonist challenge and improves the actions of the muscarinic agonist and NO donor. The present work demonstrated that the relaxant mechanism of 7-HC in SHR involves endothelium-independent vasorelaxant factors. Additionally, 7-HC reduced vasoconstriction of the sympathetic agonist while improving vascular endothelium-dependent and independent relaxation.

Citing Articles

7-hydroxycoumarin ameliorates ulcerative colitis in mice by inhibiting the MAPK pathway and alleviating gut microbiota dysbiosis.

Liu M, Sun H, Fu H, Fu L, Zheng X, Chen Y BMC Gastroenterol. 2024; 24(1):405.

PMID: 39533196 PMC: 11555800. DOI: 10.1186/s12876-024-03499-y.


Identification of a Novel Subtype-Selective α-Adrenoceptor Antagonist.

Abdul-Ridha A, de Zhang L, Betrie A, Deluigi M, Vaid T, Whitehead A ACS Chem Neurosci. 2024; 15(3):671-684.

PMID: 38238043 PMC: 10854767. DOI: 10.1021/acschemneuro.3c00767.


Umbelliferon: a review of its pharmacology, toxicity and pharmacokinetics.

Lin Z, Cheng X, Zheng H Inflammopharmacology. 2023; 31(4):1731-1750.

PMID: 37308634 DOI: 10.1007/s10787-023-01256-3.

References
1.
Cox R, Lozinskaya I, Dietz N . Differences in K+ current components in mesenteric artery myocytes from WKY and SHR. Am J Hypertens. 2001; 14(9 Pt 1):897-907. DOI: 10.1016/s0895-7061(01)02145-8. View

2.
Meisheri K, Cipkus L, Taylor C . Mechanism of action of minoxidil sulfate-induced vasodilation: a role for increased K+ permeability. J Pharmacol Exp Ther. 1988; 245(3):751-60. View

3.
Rossi A, Taylor C . IP receptors - lessons from analyses . J Cell Sci. 2018; 132(4). DOI: 10.1242/jcs.222463. View

4.
Cox R, Rusch N . New expression profiles of voltage-gated ion channels in arteries exposed to high blood pressure. Microcirculation. 2002; 9(4):243-57. DOI: 10.1038/sj.mn.7800140. View

5.
He J, Zhang W, He L, Cao Y . Imperatorin induces vasodilatation possibly via inhibiting voltage dependent calcium channel and receptor-mediated Ca2+ influx and release. Eur J Pharmacol. 2007; 573(1-3):170-5. DOI: 10.1016/j.ejphar.2007.06.043. View